Literature DB >> 21326295

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Ying Jin1, Stanca A Birlea, Pamela R Fain, Katherine Gowan, Sheri L Riccardi, Paulene J Holland, Dorothy C Bennett, Deborah M Herbstman, Margaret R Wallace, Wayne T McCormack, E Helen Kemp, David J Gawkrodger, Anthony P Weetman, Mauro Picardo, Giovanni Leone, Alain Taïeb, Thomas Jouary, Khaled Ezzedine, Nanny van Geel, Jo Lambert, Andreas Overbeck, Richard A Spritz.   

Abstract

Generalized vitiligo is a common autoimmune disease in which acquired patchy depigmentation of skin, hair, and mucous membranes results from loss of melanocytes from involved areas. Previous genetic analyses have focused on vitiligo susceptibility, and have identified a number of genes involved in disease risk. Age of onset of generalized vitiligo also involves a substantial genetic component, but has not previously been studied systematically. In this study, we report a genome-wide association study of vitiligo age of onset in 1,339 generalized vitiligo patients, with replication in an independent cohort of 677 cases. We identified a quantitative trait locus for vitiligo age of onset in the major histocompatibility complex (MHC) class II region, located near c6orf10-BTNL2 (rs7758128; P=8.14 × 10(-11)), a region that is also associated with generalized vitiligo susceptibility. In contrast, there was no association of vitiligo age of onset with any other MHC or non-MHC loci that are associated with vitiligo susceptibility. These findings highlight the differing roles played by genes involved in vitiligo susceptibility versus vitiligo age of onset, and illustrate that genome-wide analyses can be used to identify genes involved in quantitative aspects of disease natural history, as well as disease susceptibility per se.

Entities:  

Mesh:

Year:  2011        PMID: 21326295      PMCID: PMC3172680          DOI: 10.1038/jid.2011.12

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci.

Authors:  T L Bugawan; W Klitz; A Blair; H A Erlich
Journal:  Tissue Antigens       Date:  2000-11

2.  Association studies for quantitative traits in structured populations.

Authors:  Silviu-Alin Bacanu; Bernie Devlin; Kathryn Roeder
Journal:  Genet Epidemiol       Date:  2002-01       Impact factor: 2.135

3.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

4.  Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

Authors:  Ruta Valentonyte; Jochen Hampe; Klaus Huse; Philip Rosenstiel; Mario Albrecht; Annette Stenzel; Marion Nagy; Karoline I Gaede; Andre Franke; Robert Haesler; Andreas Koch; Thomas Lengauer; Dirk Seegert; Norbert Reiling; Stefan Ehlers; Eberhard Schwinger; Matthias Platzer; Michael Krawczak; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  Nat Genet       Date:  2005-02-27       Impact factor: 38.330

5.  Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.

Authors:  M J Simmonds; J M Heward; J C Barrett; J A Franklyn; S C L Gough
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

6.  HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.

Authors:  Pamela R Fain; Sunanda R Babu; Dorothy C Bennett; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2006-02

7.  Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus.

Authors:  Gisela Orozco; Peter Eerligh; Elena Sánchez; Sasha Zhernakova; Bart O Roep; Miguel A González-Gay; Miguel A López-Nevot; Jose L Callejas; Carmen Hidalgo; Dora Pascual-Salcedo; Alejandro Balsa; María F González-Escribano; Bobby P C Koeleman; Javier Martín
Journal:  Hum Immunol       Date:  2006-03-09       Impact factor: 2.850

8.  MHC fine mapping of human type 1 diabetes using the T1DGC data.

Authors:  C He; S Hamon; D Li; S Barral-Rodriguez; J Ott
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Common variants in FOXP1 are associated with generalized vitiligo.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Christina M Mailloux; Sheri L Riccardi; Katherine Gowan; Paulene J Holland; Dorothy C Bennett; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

10.  Pattern of familial aggregation of vitiligo.

Authors:  P P Majumder; J J Nordlund; S K Nath
Journal:  Arch Dermatol       Date:  1993-08
View more
  21 in total

1.  A genome-wide association study reveals that variants within the HLA region are associated with risk for nonobstructive azoospermia.

Authors:  Han Zhao; Jianfeng Xu; Haobo Zhang; Jielin Sun; Yingpu Sun; Zhong Wang; Jiayin Liu; Qiang Ding; Shaoming Lu; Rong Shi; Li You; Yingying Qin; Xiaoming Zhao; Xiaoling Lin; Xiao Li; Junjie Feng; Li Wang; Jeffrey M Trent; Chengyan Xu; Ying Gao; Bo Zhang; Xuan Gao; Jingmei Hu; Hong Chen; Guangyu Li; Junzhao Zhao; Shuhua Zou; Hong Jiang; Cuifang Hao; Yueran Zhao; Jinglong Ma; S Lilly Zheng; Zi-Jiang Chen
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

2.  Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci.

Authors:  Rosalind S Brown; Angela Lombardi; Alia Hasham; David A Greenberg; Joshua Gordon; Erlinda Concepcion; Sara S Hammerstad; Vaneet Lotay; Weijia Zhang; Yaron Tomer
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

Review 3.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 4.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

5.  Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Authors:  Roselyne Y Wagner; Flavie Luciani; Muriel Cario-André; Alain Rubod; Valérie Petit; Laila Benzekri; Khaled Ezzedine; Sébastien Lepreux; Eirikur Steingrimsson; A Taieb; Yvon Gauthier; Lionel Larue; Véronique Delmas
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 6.  Recent progress in the genetics of generalized vitiligo.

Authors:  Richard A Spritz
Journal:  J Genet Genomics       Date:  2011-06-12       Impact factor: 4.275

7.  Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.

Authors:  Xiangfeng Lu; Laiyuan Wang; Shufeng Chen; Lin He; Xueli Yang; Yongyong Shi; Jing Cheng; Liang Zhang; C Charles Gu; Jianfeng Huang; Tangchun Wu; Yitong Ma; Jianxin Li; Jie Cao; Jichun Chen; Dongliang Ge; Zhongjie Fan; Ying Li; Liancheng Zhao; Hongfan Li; Xiaoyang Zhou; Lanying Chen; Donghua Liu; Jingping Chen; Xiufang Duan; Yongchen Hao; Ligui Wang; Fanghong Lu; Zhendong Liu; Cailiang Yao; Chong Shen; Xiaodong Pu; Lin Yu; Xianghua Fang; Lihua Xu; Jianjun Mu; Xianping Wu; Runping Zheng; Naqiong Wu; Qi Zhao; Yun Li; Xiaoli Liu; Mengqin Wang; Dahai Yu; Dongsheng Hu; Xu Ji; Dongshuang Guo; Dongling Sun; Qianqian Wang; Ying Yang; Fangchao Liu; Qunxia Mao; Xiaohua Liang; Jingfeng Ji; Panpan Chen; Xingbo Mo; Dianjiang Li; Guoping Chai; Yida Tang; Xiangdong Li; Zhenhan Du; Xuehui Liu; Chenlong Dou; Zili Yang; Qingjie Meng; Dong Wang; Renping Wang; Jun Yang; Heribert Schunkert; Nilesh J Samani; Sekar Kathiresan; Muredach P Reilly; Jeanette Erdmann; Xiaozhong Peng; Xigui Wu; Depei Liu; Yuejin Yang; Runsheng Chen; Boqin Qiang; Dongfeng Gu
Journal:  Nat Genet       Date:  2012-07-01       Impact factor: 38.330

8.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

Review 9.  The role of IL-17 in vitiligo: A review.

Authors:  Rasnik K Singh; Kristina M Lee; Ivan Vujkovic-Cvijin; Derya Ucmak; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Tina Bhutani; Maria Wei; Wilson Liao
Journal:  Autoimmun Rev       Date:  2016-01-21       Impact factor: 9.754

10.  Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent.

Authors:  Stanca A Birlea; Fridoon J Ahmad; Raza M Uddin; Shakil Ahmad; Sabrina S Pal; Rasheedunnisa Begum; Naresh C Laddha; Mitesh Dwivedi; Mohmmad Shoab Mansuri; Ying Jin; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Songtao Ben; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2013-01-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.